1 / 8

Intraocular Lens (IOL) Market

The Intraocular Lens (IOL) Market size was valued at USD 3.94 Billion in 2023 and the total Intraocular Lens (IOL) revenue is expected to grow at a CAGR of 4.32 % from 2024 to 2030, reaching nearly USD 5.30 Billion by 2030.<br>

pchetana
Télécharger la présentation

Intraocular Lens (IOL) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intraocular Lens (IOL) Marketglobal Analysis Report 2024-30 Published by: Chetana, HealthcareSpecialist

  2. Market Size & Overview: The global intraocular lens (IOL) market was valued at approximately USD 3.94 billion in 2023 and is projected to reach around USD 5.30 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.32% during the forecast period. IOLs are artificial lenses implanted in the eye to replace the natural lens during cataract surgery or to correct refractive errors, thereby restoring vision.

  3. Market Growth & Opportunities The market is primarily driven by the increasing prevalence of cataracts, especially among the aging population, leading to a higher number of cataract surgeries. Technological advancements have resulted in the development of premium IOLs, such as toric, multifocal, and accommodating lenses, which address specific vision impairments like astigmatism and presbyopia. These innovations offer enhanced visual outcomes and improved patient satisfaction, presenting significant growth opportunities. However, the high cost of premium IOLs and limited access to advanced healthcare facilities in certain regions may pose challenges to market expansion. Sample Request

  4. Market Segmentation • by Flexibility • Foldable • Rigid • by Application • Cataract Surgery • Presbyopia • Corneal Disorders • Others • by End User • Hospitals • Ambulatory Surgery Centers • Ophthalmology Clinics • Eye Research Institutes by Type • Monofocal IOLs • Premium IOLs • Phakic IOLs • Others by Material • Hydrophobic Acrylic IOLs • Hydrophilic Acrylic IOLs • PolyMethylMethAcrylate • Silicone IOLs • Others

  5. Regional Analysis: • North America: This region dominates the IOL market, attributed to a high prevalence of vision-related disorders and the adoption of advanced healthcare technologies. The United States, in particular, has a significant number of presbyopia cases, with approximately 128 million individuals affected, a number that continues to rise due to the aging population. Substantial healthcare investments further bolster market growth in this region. • Europe: Europe holds the second-largest market share, driven by an aging population and a high demand for cataract surgeries. Innovations in IOL technologies and the presence of key market players contribute to the market's expansion in this region. • Asia-Pacific (APAC): APAC is expected to witness significant growth due to the high prevalence of eye-related conditions, such as cataracts and diabetic retinopathy. Factors like increasing medical tourism for eye surgeries, expanding insurance coverage, and improved diagnosis of eye diseases contribute to the rising demand for IOLs in this region.

  6. Regional Analysis Customized Report Request

  7. Merges and Acquisition • Johnson & Johnson's Acquisition of Abbott Medical Optics: In 2017, Johnson & Johnson acquired Abbott Medical Optics, expanding its vision care portfolio to include a range of IOLs and other ophthalmic products. • Alcon's Acquisition of PowerVision: In 2019, Alcon acquired PowerVision, a company specializing in fluid-based lens implants designed to restore vision across all distances, enhancing Alcon's IOL offerings. • Bausch + Lomb's Acquisition of AcuFocus: In January 2023, Bausch + Lomb acquired AcuFocus, an ophthalmic medical device company known for its small aperture intraocular technology, aiming to address diverse unmet needs in eye care. Buy This Report

  8. Thank You Get In Touch with US: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 sales@maximizemarketresearch.com

More Related